文献速递眼底病与葡萄膜炎

0.18毫克氟轻松醋酸酯植入剂治疗慢性白内障术后人工晶状体眼黄斑囊样水肿

0.18 MG FLUOCINOLONE ACETONIDE INSERT FOR THE TREATMENT OF CHRONIC POSTOPERATIVE PSEUDOPHAKIC CYSTOID MACULAR EDEMA.
PubMed 文献 · Retina · 2023-01-01

回顾性连续病例系列纳入13例患者19只眼,评估0.18毫克氟轻松醋酸酯植入剂治疗白内障术后慢性黄斑囊样水肿(病程超过6个月)的效果。平均随访15.4个月,10只眼(52.6%)视力提高至少2行,16只眼(84.2%)黄斑中心凹厚度降低至少20%,8只眼(42.1%)水肿完全消退,植入后需要补充局部皮质类固醇的眼数减少。

要点

  • 10只眼(52.6%)视力提高至少2行,16只眼(84.2%)黄斑中心凹厚度降低至少20%。
  • 8只眼(42.1%)黄斑囊样水肿完全消退,中心凹厚度和视力改善在随访中持续。
  • 植入后需补充局部皮质类固醇的眼数从18只(94.7%)降至6只(31.6%),需皮质类固醇滴眼液的眼数从12只(63.2%)降至3只(15.8%)。

核心结论

  • 白内障术后慢性黄斑囊样水肿眼接受0.18毫克氟轻松醋酸酯植入剂治疗后,视力和光学相干断层扫描指标改善且持续,补充治疗负担降低。

研究设计与样本

  • 回顾性连续病例系列,纳入13例患者19只眼,均为白内障术后慢性(超过6个月)黄斑囊样水肿并接受0.18毫克氟轻松醋酸酯植入剂治疗。

主要发现

  • 平均随访15.4个月,10只眼(52.6%)视力提高至少2行。
  • 16只眼(84.2%)光学相干断层扫描黄斑中心凹厚度降低至少20%。
  • 8只眼(42.1%)黄斑囊样水肿完全消退。
  • 中心凹厚度和视力改善在各自随访期间持续。
  • 植入前18只眼(94.7%)需补充局部皮质类固醇,植入后仅6只眼(31.6%)需补充;植入前12只眼(63.2%)使用皮质类固醇滴眼液,植入后仅3只眼(15.8%)需使用。

关键数值与推荐

  • 慢性术后黄斑囊样水肿定义为白内障术后病程超过6个月。
  • 视力提高至少2行见于10只眼(52.6%)。
  • 黄斑中心凹厚度降低至少20%见于16只眼(84.2%)。
  • 黄斑囊样水肿完全消退见于8只眼(42.1%)。

临床怎么用

  • 对于白内障术后慢性黄斑囊样水肿眼,0.18毫克氟轻松醋酸酯植入剂可改善视力和光学相干断层扫描指标,并降低补充局部皮质类固醇的需求。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To report the outcomes of the 0.18 mg fluocinolone acetonide insert (FAi) in the treatment of chronic (>6 months) postoperative cystoid macular edema after cataract surgery. METHODS: This was a retrospective consecutive case series of eyes with chronic postoperative cystoid macular edema treated with the FAi. Visual acuity, intraocular pressure, optical coherence tomography metrics, and supplemental therapies were extracted from the charts before and at 3, 6, 12, 18, and 21 months after FAi placement, when available. RESULTS: Nineteen eyes of 13 patients with chronic postoperative cystoid macular edema after cataract surgery underwent FAi placement with an average follow-up of 15.4 months. Ten eyes (52.6%) had a ≥2-line gain in visual acuity. Sixteen eyes (84.2%) had a ≥20% reduction in optical coherence tomography central subfield thickness. Eight eyes (42.1%) had complete resolution of CME. Improvements in central subfield thickness and visual acuity were sustained throughout individual follow-up. Compared with 18 eyes (94.7%) requiring local corticosteroid supplementation before FAi, only six eyes (31.6%) required supplementation after FAi. Similarly, of the 12 eyes (63.2%) that were on corticosteroid drops before FAi, only 3 (15.8%) required drops after FAi. CONCLUSION: Eyes with chronic postoperative cystoid macular edema after cataract surgery treated with the FAi had improved and sustained visual acuity and optical coherence tomography metrics, along with a reduction in supplemental treatment burden.

来源:Retina,查看原文。版权归原作者所有。

引用

  1. Deaner JD, Mammo D, Gross A, et al. 0.18 MG FLUOCINOLONE ACETONIDE INSERT FOR THE TREATMENT OF CHRONIC POSTOPERATIVE PSEUDOPHAKIC CYSTOID MACULAR EDEMA. Retina. 2023. PMID: 36796039. doi:10.1097/IAE.0000000000003765

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。